
FDA chooses flu vaccine strains despite cancelled meeting
The FDA has released its recommendations on the composition of influenza vaccines for the 2025-26 season – without the input of its external advisors.
Newsletters and Deep Dive digital magazine
The FDA has released its recommendations on the composition of influenza vaccines for the 2025-26 season – without the input of its external advisors.
The UK pharma sector has reacted with consternation to the government's proposal to raise the Statutory Scheme rate to 32.2% in the last half of 2025.
Two pharmas that filed for bankruptcy protection due to opioid litigation in the US – Mallinckrodt and Endo – are rumoured to be in merger talks.
“Medicated weight loss isn’t cheating.” Since I first wrote about the rise of
Kelun-Biotech wins first global regulatory approval - in China - for a TROP2-directed antibody-drug conjugate (ADC) in lung cancer.
Editor's Picks
Newsletters and Deep Dive
digital magazine